Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    DevOp
    wrote on sidst redigeret af
    #798

    Ja, men prøv at se 2018, der lå dec lavere end okt og
    nov

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #799

      Bliver det lavere end nov, begynder det at stramme til.

      1 Reply Last reply
      0
      • K Offline
        K Offline
        KWC
        wrote on sidst redigeret af
        #800

        Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
        Company Announcement

        DARZALEX® (daratumumab) approved in Europe in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant
        Approval follows positive opinion by European Committee for Medicinal Produ

        1 Reply Last reply
        0
        • K Offline
          K Offline
          KWC
          wrote on sidst redigeret af
          #801

          Copenhagen, Denmark; January 20, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The EC approval follows a positive opinion issued for DARZALEX by the CHMP of the European Medicines Agency (EMA) in Decemb

          1 Reply Last reply
          0
          • K Offline
            K Offline
            KWC
            wrote on sidst redigeret af
            #802

            “With this approval, newly diagnosed patients with multiple myeloma who are eligible for ASCT may have the opportunity for treatment with a DARZALEX-containing regimen. We are extremely pleased that DARZALEX has received this latest approval and we look forward to the combination of DARZALEX plus bortezomib, thalidomide and dexamethasone being launched in Europe,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

            The approval was based on the Phase III CASSIOPEIA (MMY3006) study

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bikube
              wrote on sidst redigeret af
              #803

              Skidt med recepttallene denne gang, vi får det færdige resultat fra JnJ samme dag. Og dagens nyhed om godkendelse i EU må trække lidt op.

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #804

                Orv - Kan du huske det Pensionisten.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #805

                  Det var hurtigt godkendelsen kom. Kun 5 uger og med jul og nytår ind imellem.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #806

                    i was thinking the exact same. Nice.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #807

                      And with Alcyone approved 1½ years ago we now have both transplant and non-transplant covered in the EU. Will probably add up sales numbers in 2020.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #808

                        They submitted application March 27 last year. So all in all it took a little less than 10 mths.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #809

                          https://www.bbc.com/news/health-51182451 Endnu en historie omkring en kur imod cancer. Lad da håbe at det denne gang er rigtigt.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            peter12
                            wrote on sidst redigeret af
                            #810

                            Såvidt jeg kan se er det en gammel historie fra Basel (og ikke Cardiff). Nok lettere tænkt end gjort ? https://elifesciences.org/articles/24476

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #811

                              Morning 🙂 Trend intact https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81007_trend_intact.JPG

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #812

                                1.5 års trend +forecast (godt til CFD handel)

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #813

                                  Link Preview Image

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #814

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #815

                                      Den er er også meget sjov og man ser tydligt CWH er intakt https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81009_sjov.JPG

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        Jørn_B
                                        wrote on sidst redigeret af
                                        #816

                                        @Stockbull. Tak... Lad os bare holde os til den sidste, så er jeg ikke utilfreds 🙂

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #817

                                          Ritzau skriver at Cassiopeia er godkendt i Japan. Det passer vist ikke. Jeg har ikke kunnet finde noget på Japan. I USA derimod er Cass godkendt. Til gengæld kan vi snart forvente godkendelse af Maia i Japan. Ansøgning 5. april.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger